Detalles de la búsqueda
1.
177Lu-Dotatate plus long-acting octreotide versus highdose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 22(12): 1752-1763, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34793718
2.
Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs.
Front Endocrinol (Lausanne)
; 10: 931, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-32117045
Resultados
1 -
2
de 2
1
Próxima >
>>